Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
DX6KWY
|
||||
| Drug Name |
N-[(3R)-1-cyano-3-pyrrolidinyl]-4-fluorobenzamide
|
||||
| Synonyms |
CHEMBL1672423
|
||||
| Indication | Discovery agent | Investigative | [1587926] | ||
| Formula |
C12H12FN3O
|
||||
| Canonical SMILES |
Fc1ccc(cc1)C(=O)N[C@@H]2CCN(C2)C#N
|
||||
| InChI |
InChI=1S/C12H12FN3O/c13-10-3-1-9(2-4-10)12(17)15-11-5-6-16(7-11)8-14/h1-4,11H,5-7H2,(H,15,17)/t11-/m1/s1
|
||||
| InChIKey |
MWHXRJQRAIXADX-LLVKDONJSA-N
|
||||
| Target and Pathway | |||||
| Target(s) | Cathepsin K | Target Info | [1587926] | ||
| Cathepsin B | Target Info | [1587926] | |||
| Reactome | Collagen degradation | ||||
| Degradation of the extracellular matrix | |||||
| Activation of Matrix Metalloproteinases | |||||
| Trafficking and processing of endosomal TLR | |||||
| MHC class II antigen presentationR-HSA-1442490:Collagen degradation | |||||
| Assembly of collagen fibrils and other multimeric structures | |||||
| MHC class II antigen presentation | |||||
| WikiPathways | RANKL/RANK Signaling Pathway | ||||
| Osteoclast Signaling | |||||
| References | |||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.